SCHEMBL3269957

SCHEMBL3269957

N#CC(=O)O.[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL8848944 0.95
SCHEMBL37136 0.95
SCHEMBL10339487 0.91
SCHEMBL4542253 0.91
Ammonia Solution, Strong SCHEMBL21838765 0.91
SCHEMBL23218025 0.91
Hydrochloric Acid SCHEMBL6643669 0.91
SCHEMBL8895617 0.91
Water SCHEMBL8502324 0.91
SCHEMBL2349643 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1191102-B1 Method for producing an active heterodimeric AMV-RT in prokaryotic cells ROCHE DIAGNOSTICS GMBH (DE) 2010-06-16 EP disclosed
US-6902920-B2 Method for producing an active heterodimeric AMV-RT in prokaryotic cells ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2005-06-07 US disclosed
US-20020115147-A1 Method for producing an active heterodimeric AMV-RT in prokaryotic cells ROCHE DIAGNOSTICS OPERATIONS, INC. 2002-08-22 US disclosed
EP-1191102-A2 Method for producing an active heterodimeric AMV-RT in prokaryotic cells Roche Diagnostics GmbH (DE) 2002-03-27 EP disclosed